ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,737.99
      0.38%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Bellevue Life Sciences Acquisition Corporation (BLACW)

      7. Bellevue Life Sciences Acquisition Corporation (BLACW) Financials

      BLACW Bellevue Life Sciences Acquisition Corporation

      0.0201
      0.00 (0.00%)
      May 31 2024 - Closed
      Delayed by 15 minutes

      Bellevue Life Sciences A... Financial Summary

      The current BLACW market cap is 182.01k. The company's latest EPS is USD 0.0446 and P/E is 240.58.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)
      Total Revenue 00000
      Operating Income -14k-278k-280k-411k-862k
      Net Income -14k110k302k78k-86k
      Year End December 30 2023 20222023
      USD ($)USD ($)
      Total Revenue 00
      Operating Income -35k-1.83M
      Net Income -35k404k

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)
      Total Assets 1.23M71.06M71.49M72.14M36.63M
      Total Liabilities 1.26M2.47M2.61M3.18M4.11M
      Total Equity -37k-1.83M-2.1M-2.46M-3.91M
      Year End December 30 2023 20222023
      USD ($)USD ($)
      Total Assets 1.23M36.63M
      Total Liabilities 1.26M4.11M
      Total Equity -37k-3.91M

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)
      Operating -4k-49k-396k-539k-819k
      Investing N/A -70.21M-70.21M-70.21M-33.83M
      Financing 124k70.48M70.48M70.68M34.54M
      Year End December 30 2023 20222023
      USD ($)USD ($)
      Operating -4k-819k
      Investing N/A -33.83M
      Financing 124k34.54M

      Stats and Ratios

      Market Cap 182.01k
      Price to Earnings Ratio 240.58
      Price to Sales Ratio 0
      Price to Cash Ratio 6.31k
      Price to Book Ratio 2.99
      Dividend Yield -

      Share Statistics

      Shares Outstanding 9.06M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.03 (55.56%)

      Company Info

      Company Name Bellevue Life Sciences Acquisition Corporation
      Address 8 the green, ste r
      dover, delaware 19901
      Website https://
      Industry blank checks (6770)